查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1968101

全球轉染試劑和儀器市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Transfection Reagents and Equipment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 169 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計轉染試劑和設備市場將從 2025 年的 20.1 億美元成長到 2034 年的 40.9 億美元，2026 年至 2034 年的複合年成長率為 8.21%。

受基因治療、CRISPR基因編輯和細胞工程研究活性化的推動，全球轉染試劑和設備市場正穩步成長。學術機構和生物製藥公司高度依賴轉染技術將遺傳物質導入細胞。對高效遞送質體DNA、mRNA和siRNA系統的需求不斷成長，推動了化學和物理轉染平台的應用。

基因治療產品線的拓展、研發經費的增加以及能夠提高轉染效率並最大限度降低細胞毒性的技術進步是推動成長的成長要素。電穿孔設備的自動化和小型化，以及針對難以轉染的原代細胞的專用試劑的開發，正在拓展基因治療的應用領域。此外，向非病毒載體系統的轉變也促進了市場需求的成長。

未來的成長將取決於符合GMP規範的臨床生產轉染解決方案和可擴展的商業性細胞治療生產平台。透過與自動化實驗室系統的整合以及脂質奈米顆粒技術的進步，預計功能將進一步增強。持續創新，專注於可重複性和成本效益，對於保持長期競爭力仍然至關重要。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球轉染試劑與儀器市場：依產品分類

  • 市場分析、洞察與預測
  • 試劑
  • 裝置

第5章 全球轉染試劑與儀器市場：依方法分類

  • 市場分析、洞察與預測
  • 電穿孔
  • 脂質體
  • 顆粒衝擊法
  • 顯微注射
  • 腺病毒載體
  • 磷酸鈣
  • DEAE-聚葡萄糖
  • 磁珠
  • 活性樹狀樹狀聚合物
  • 雷射感染

第6章 全球轉染試劑與儀器市場：依應用分類

  • 市場分析、洞察與預測
  • 基因表現研究
  • 蛋白質生產
  • 基因改造模型
  • 藥物輸送
  • 癌症研究
  • 生物醫學研究

第7章 全球轉染試劑和儀器市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 學術研究機構
  • 製藥和生物技術公司

第8章 全球轉染試劑和儀器市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher Scientific Inc
    • Promega Corporation
    • Lonza
    • QIAGEN
    • F. Hoffmann-La Roche Ltd
    • Bio-Rad Laboratories Inc
    • Merck KGaA
    • OriGene Technologies Inc
    • MaxCyte
    • Polyplus
簡介目錄
Product Code: VMR112110212

The Transfection Reagents and Equipment Market size is expected to reach USD 4.09 Billion in 2034 from USD 2.01 Billion (2025) growing at a CAGR of 8.21% during 2026-2034.

The Global Transfection Reagents and Equipment market is growing steadily due to increased activity in gene therapy, CRISPR gene editing, and cell engineering research. Academic institutions and biopharmaceutical companies rely heavily on transfection technologies for introducing genetic material into cells. Rising demand for efficient delivery systems for plasmid DNA, mRNA, and siRNA is fueling adoption of both chemical and physical transfection platforms.

Growth drivers include expanding gene therapy pipelines, higher research funding, and technological improvements that enhance transfection efficiency while minimizing cytotoxicity. Automation and miniaturization of electroporation instruments, along with development of specialized reagents for hard-to-transfect primary cells, are broadening application areas. The shift toward non-viral delivery systems also supports increasing market demand.

Future growth will be shaped by GMP-compatible transfection solutions for clinical manufacturing and scalable platforms for commercial cell therapy production. Integration with automated laboratory systems and advancements in lipid nanoparticle technologies will further expand capabilities. Continued innovation focused on reproducibility and cost efficiency will remain essential for long-term competitiveness.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Reagents
  • Equipment

By Method

  • Electroporation
  • Liposomes
  • Particle Bombardment
  • Microinjection
  • Adenoviral Vectors
  • Calcium Phosphate
  • DEAE-dextran
  • Magnetic Beads
  • Activated Dendrimers
  • Laserfection

By Application

  • Gene Expression Studies
  • Protein Production
  • Transgenic Models
  • Therapeutic Delivery
  • Cancer Research
  • Biomedical Research

By End User

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies

COMPANIES PROFILED

  • Thermo Fisher Scientific Inc, Promega Corporation, Lonza, QIAGEN, F HoffmannLa Roche Ltd, BioRad Laboratories Inc, Merck KGaA, OriGene Technologies Inc, MaxCyte, Polyplus
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHOD 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Method
  • 5.2. Electroporation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Liposomes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Particle Bombardment Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Microinjection Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Adenoviral Vectors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Calcium Phosphate Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.8. DEAE-dextran Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.9. Magnetic Beads Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.10. Activated Dendrimers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.11. Laserfection Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Gene Expression Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Protein Production Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Transgenic Models Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Therapeutic Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Cancer Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.7. Biomedical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Method
    • 8.2.3 By Application
    • 8.2.4 By End User
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Method
    • 8.3.3 By Application
    • 8.3.4 By End User
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Method
    • 8.4.3 By Application
    • 8.4.4 By End User
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Method
    • 8.5.3 By Application
    • 8.5.4 By End User
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Method
    • 8.6.3 By Application
    • 8.6.4 By End User
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Thermo Fisher Scientific Inc
    • 10.2.2 Promega Corporation
    • 10.2.3 Lonza
    • 10.2.4 QIAGEN
    • 10.2.5 F. Hoffmann-La Roche Ltd
    • 10.2.6 Bio-Rad Laboratories Inc
    • 10.2.7 Merck KGaA
    • 10.2.8 OriGene Technologies Inc
    • 10.2.9 MaxCyte
    • 10.2.10 Polyplus